Mineralys Therapeutics reports positive lorundrostat clinical data

Created at 6 Jun · 00:47 UTC1 source↑ Market-relevant

IN SHORT

Mineralys Therapeutics announced encouraging clinical efficacy data for its drug lorundrostat. The company disclosed the information via a press release.

Who's Involved

Mineralys Therapeutics

Company announcing clinical efficacy data for lorundrostat

Key facts

Mineralys Therapeutics announced positive clinical efficacy data for lorundrostat.
The data was disclosed in a press release.

Mineralys Therapeutics announced encouraging data regarding the clinical efficacy of its drug, lorundrostat. The company disclosed this information through a press release.

↳ Why This Matters

Positive clinical trial data for a drug candidate can significantly impact a biotechnology company's valuation and future prospects.

FREQUENTLY ASKED

Mineralys Therapeutics announced data for its drug lorundrostat.

The company announced encouraging data regarding the clinical efficacy of lorundrostat.

The data was announced via a press release from Mineralys Therapeutics.

Get the newsletter.

Pick the topics you actually care about. We'll email when there's news worth your time, on the cadence you choose. Cancel any time from your account.

Cadence

How It Developed

5 Jun · 15:55 UTC

Mineralys Therapeutics announced encouraging clinical efficacy data for lorundrostat in a press release.

Yahoo News | Finance Top Stories via PiQSuite

Sources

Mineralys Therapeutics (MLYS) Shares Encouraging Data for Lorundrostat Clinical Efficacy

Mineralys Therapeutics reports positive lorundrostat clinical data

PiQ Daily

Key facts

Get the newsletter.

Mineralys Therapeutics reports positive lorundrostat clinical data

PiQ Daily

Key facts

Get the newsletter.